Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as methotrexate and thiotepa, work in different
ways to stop cancer cells from dividing so they stop growing or die. Combining more than one
drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining methotrexate with thiotepa in
treating patients who have newly-diagnosed primary CNS lymphoma.